Reproducibility and usefulness of quantitative apparent diffusion coefficient measurements for predicting program death-ligand 1 expression in nasopharyngeal carcinoma

被引:0
|
作者
Xi Zhong
Li Li
Jinxue Yin
Yuanlin Chen
Xin Xin
Lanlan Yu
Yongfang Tang
Jiangyu Zhang
Jiansheng Li
机构
[1] Affiliated Cancer Hospital & Institute of Guangzhou Medical University,Department of Medical Imaging
[2] The Third Affiliated Hospital of Guangzhou Medical University,Department of Otolaryngology
[3] Affiliated Cancer Hospital & Institute of Guangzhou Medical University,Department of Pathology
来源
关键词
Nasopharyngeal carcinoma; Programmed death ligand 1; Magnetic resonance imaging; Apparent diffusion coefficients;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Reproducibility and usefulness of quantitative apparent diffusion coefficient measurements for predicting program death-ligand 1 expression in nasopharyngeal carcinoma
    Zhong, Xi
    Li, Li
    Yin, Jinxue
    Chen, Yuanlin
    Xin, Xin
    Yu, Lanlan
    Tang, Yongfang
    Zhang, Jiangyu
    Li, Jiansheng
    CANCER IMAGING, 2023, 23 (01)
  • [2] The Prognostic Role of Programmed Death-Ligand 1 in Nasopharyngeal Carcinoma
    Wotman, Michael
    Herman, Saori W.
    Costantino, Peter
    Tham, Tristan
    LARYNGOSCOPE, 2020, 130 (11): : 2598 - 2606
  • [3] Programmed death-ligand 1 expression in carcinoma of unknown primary
    Kim, Hye Min
    Koo, Ja Seung
    BMC CANCER, 2024, 24 (01)
  • [4] Programmed Death-ligand 1 Expression in Upper Tract Urothelial Carcinoma
    Skala, Stephanie L.
    Liu, Tzu-Ying
    Udager, Aaron M.
    Weizer, Alon Z.
    Montgomery, Jeffrey S.
    Palapattu, Ganesh S.
    Siddiqui, Javed
    Cao, Xuhong
    Fields, Kristina
    Abugharib, Ahmed E.
    Soliman, Moaaz
    Hafez, Khaled S.
    Miller, David
    Lee, Cheryl T.
    Alva, Ajjai
    Chinnaiyan, Arul M.
    Morgan, Todd M.
    Spratt, Daniel E.
    Jiang, Hui
    Mehra, Rohit
    EUROPEAN UROLOGY FOCUS, 2017, 3 (4-5): : 502 - 509
  • [5] Programmed death-ligand 1 expression in the immune compartment of colon carcinoma
    Yilmaz, Osman
    Pankaj, Amaya
    Neyez, Azfar
    Rickelt, Steffen
    Taylor, Martin
    Lang, Evan R.
    Leijsen, Lieve
    Dinaux, Anne
    Shroff, Stuti G.
    Crotty, Rory
    Zhang, M. Lisa
    Cerda, Sandra
    Zhao, Qing
    Ferrone, Cristina
    Ting, David T.
    Patil, Deepa T.
    Yilmaz, Omer
    Berger, David
    Deshpande, Vikram
    MODERN PATHOLOGY, 2022, 35 (11) : 1740 - 1748
  • [6] High Soluble Programmed Death-Ligand 1 Predicts Poor Prognosis in Patients with Nasopharyngeal Carcinoma
    Lu, Tianzhu
    Chen, Yiping
    Li, Jieyu
    Guo, Qiaojuan
    Lin, Wansong
    Zheng, Yuhong
    Su, Ying
    Zong, Jingfeng
    Lin, Shaojun
    Ye, Yunbin
    Pan, Jianji
    ONCOTARGETS AND THERAPY, 2020, 13 : 1757 - 1765
  • [7] Immunohistochemistry Expression of Programmed Death-Ligand 1 in Colorectal Carcinoma among Nigerians
    Badmos, K. B.
    Odukoya, L. A.
    Khramtsova, G. F.
    Adebayo, L. A.
    Olopade, O., I
    Abdulkareem, F. B.
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2024, 27 (11) : 1239 - 1244
  • [8] Expression and clinical significance of programmed death ligand 1 in nasopharyngeal carcinoma
    Qu, Yuan
    Wang, Di
    Yang, Lin
    Liu, Hui-Ying
    Cui, Wei
    Che, Yi-Qun
    MOLECULAR AND CLINICAL ONCOLOGY, 2018, 9 (01) : 75 - 81
  • [9] Transarterial chemoembolisation enhances programmed death-1 and programmed death-ligand 1 expression in hepatocellular carcinoma
    Montasser, Ahmed
    Beaufrere, Aurelie
    Cauchy, Francois
    Bouattour, Mohamed
    Soubrane, Olivier
    Albuquerque, Miguel
    Paradis, Valerie
    HISTOPATHOLOGY, 2021, 79 (01) : 36 - 46
  • [10] Programmed death-ligand 1 (PD-L1) expression in pleomorphic carcinoma of the lung
    Imanishi, Naoko
    Hirai, Ayako
    Yoneda, Kazue
    Shimajiri, Shohei
    Kuwata, Taiji
    Tashima, Yuko
    Takeuchi, Masahiro
    Iwai, Yoshiko
    Ichiki, Yoshinobu
    Tanaka, Fumihiro
    JOURNAL OF SURGICAL ONCOLOGY, 2018, 117 (07) : 1563 - 1569